Abstract: The present invention describes compositions that are useful for making artificial fingernails, in particular such compositions that are odorless, non-toxic, self-curing, and demonstrate good working properties as described above.Compositions in accordance with this invention consist of two parts:(a) an odorless, non-toxic liquid binder comprising one or more methacrylate monomer(s) of the following formula:R--O--CH.sub.2 CH.sub.2 --O--CH.sub.2 CH.sub.2 --O--CO--C(CH.sub.3).dbd.CH.sub.2where R is CH.sub.3 (CH.sub.2).sub.n and n=0-3 together with one or more di-, tri-, or multi-functional methacrylates, and a tertiary-amine type accelerator; and(b) a polymeric powder containing a finely divided methacrylate polymer or copolymer, and a peroxide polymerization initiator.

Abstract: A sugarless ingestible gel confectionary delivery system which includes a pectin gel component, an algin gel component and a polymer network gel component in amounts sufficient to form a gel confectionery unit. The inventive gel confectionery unit has reduced intrinsic viscosity prior to gelation which permits the inclusion of an edible insoluble solid in an amount sufficient to strengthen the internal combination pectin-algin gel network and to bind internal moisture sufficiently to enhance mold removal capabilities. The delivery system also includes hydrogenated starch hydrolysates. The delivery system may also include a further active ingredient such as a drug, medicament, or nutritional supplement. The product and method of the present invention also includes a composition in which the gel delivery system can be molded directly in the receptacle which is used to dispense the confectionery unit to the consumer.

Abstract: A medicinal preparation for individual prevention of venereal diseases and treatment of urogenital trichomoniasis comprises an efficient quantity of an active principle which is essentially a synergistic mixture of para-nitro-alpha-chlorocinnamic aldehyde of the formula: ##STR1## dimethylsulphoxide and a pharmaceutical excipient. Polyethyleneglycol having a molecular mass of 400 is recommended to be used as the pharmaceutical excipient.A method for treatment of urogenital trichomoniasis consists in application of the medicinal preparation in question to the mucosa of human genitalia in a dose of 1.5 to 10 ml twice a day for 5 to 7 days.